Fulgent Genetics, Inc.
$493.16M- Market cap
- $542.88M
- Debt
- +$476.00K
- Cash
- −$50.19M
Capital structure 100% equity / 0% debt · EV / Revenue 1.53x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: FLGT stock price at discount vs TDG $19.73 current versus $85.30 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at TDG's multiple
Implied fair value · at FLGT's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: FLGT FY 2025 (ended Dec 31, 2025) · TDG FY 2025 (ended Sep 30, 2025). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 100% equity / 0% debt · EV / Revenue 1.53x
Capital structure 69% equity / 31% debt · EV / Revenue 10.29x · EV / EBITDA 20.30x
TDG carries the larger enterprise value at $90.84B against $493.16M; FLGT trades on the lower EV / Revenue multiple (1.53x vs 10.29x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
FULGENT GENETICS, INC. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
TransDigm Group Incorporated · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.00x
-3.04x
Net debt / EBITDA
Leverage against operating earnings
1.15x
5.95x
Cash and equivalents
Liquid reserves on the balance sheet
$50.19M
$2.81B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
NEOGENOMICS INC
FLGT vs NEO
Natera, Inc.
FLGT vs NTRA
Guardant Health, Inc.
FLGT vs GH
EXACT SCIENCES CORP
FLGT vs EXAS
OPKO HEALTH, INC.
FLGT vs OPK
BOEING CO
FLGT vs BA
LOCKHEED MARTIN CORP
FLGT vs LMT
NORTHROP GRUMMAN CORP /DE/
FLGT vs NOC
AAR CORP
FLGT vs AIR
Howmet Aerospace Inc.
FLGT vs HWM
$476.00K
$29.42B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.